US FDA premarket approval of tDCS depression treatment is not yet scientifically justified

Jana Klaus; Fenne M. Smits; André Aleman; Chris Baeken; Philip van Eijndhoven; Odile A. van den Heuvel; Dennis J.L.G. Schutter

doi:10.1016/S2215-0366(26)00092-1

US FDA premarket approval of tDCS depression treatment is not yet scientifically justified

Jana Klaus^*
, Fenne M. Smits
, André Aleman
, Chris Baeken
, Philip van Eijndhoven
, Odile A. van den Heuvel
, Dennis J.L.G. Schutter

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	726-728
Number of pages	3
Journal	Lancet Psychiatry
Volume	13
Issue number	9
Early online date	16 Apr 2026
DOIs	https://doi.org/10.1016/S2215-0366(26)00092-1
Publication status	Published - Sept 2026

Access to Document

10.1016/S2215-0366(26)00092-1

Cite this

@article{d1ee971e24374e19b88925a12bacad02,

title = "US FDA premarket approval of tDCS depression treatment is not yet scientifically justified",

author = "Jana Klaus and Smits, \{Fenne M.\} and Andr{\'e} Aleman and Chris Baeken and \{van Eijndhoven\}, Philip and \{van den Heuvel\}, \{Odile A.\} and Schutter, \{Dennis J.L.G.\}",

year = "2026",

month = sep,

doi = "10.1016/S2215-0366(26)00092-1",

language = "English",

volume = "13",

pages = "726--728",

journal = "Lancet Psychiatry",

issn = "2215-0374",

publisher = "Elsevier Ltd",

number = "9",

}

TY - JOUR

T1 - US FDA premarket approval of tDCS depression treatment is not yet scientifically justified

AU - Klaus, Jana

AU - Smits, Fenne M.

AU - Aleman, André

AU - Baeken, Chris

AU - van Eijndhoven, Philip

AU - van den Heuvel, Odile A.

AU - Schutter, Dennis J.L.G.

PY - 2026/9

Y1 - 2026/9

U2 - 10.1016/S2215-0366(26)00092-1

DO - 10.1016/S2215-0366(26)00092-1

M3 - Comment/Letter to the editor

SN - 2215-0374

VL - 13

SP - 726

EP - 728

JO - Lancet Psychiatry

JF - Lancet Psychiatry

IS - 9

ER -